TARGETING GLYCOIMMUNE CHECKPOINTS SIGLEC-7 AND -9 FOR THE TREATMENT OF COLORECTAL CANCER

$718,032FY2025Defense Health AgencyDOD

Scripps Research Institute, La Jolla CA

Investigators